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The discovery that transient elevations of calcium concentration occur in astrocytes, 
and release “gliotransmitters” which act on neurons and vascular smooth muscle, led 
to the concept of astrocytes being powerful regulators of neuronal spiking, synaptic 
plasticity and brain blood flow. These findings were challenged by a second wave of 
reports that astrocyte calcium transients did not mediate functions attributed to 
gliotransmitters and were too slow to generate blood flow increases. Remarkably, the 
tide has now turned again: the most important calcium transients occur in fine 
astrocyte processes not resolved in earlier studies, and new mechanisms have been 
discovered by which astrocyte [Ca2+]i is raised and has its effects. Here we review how 
this third wave of discoveries has changed our understanding of astrocyte calcium 
signalling and its consequences for neuronal function. 
Few topics in neuroscience are as controversial as the idea that calcium concentration 
elevations in astrocytes release transmitters that regulate neuronal and vascular function. As 
an example, highly respected scientists in the field have stated on the one hand that1 
astrocytes show “Ca2+-dependent quantal glutamate release...previously considered to be 
specific to synapses” and on the other hand that2 “the case for regulated release of glutamate 
from astrocytes onto neurons...is not convincing” and3 “it is very difficult to conclude that 
astrocytes possess the...machinery required for Ca2+-dependent release of glutamatergic 
vesicles”. How could these mutually incompatible views arise? In this Perspective we will 
review briefly the turbulent history of the field, survey recent data suggesting a way out of 
some of the reported contradictions, and speculate on the future direction of research in this 
area.  
The first wave - astrocytes also process information 
 The discovery that glutamate evokes a calcium concentration rise in astrocytes4-8 (in 
culture, in brain slices, in whole retina and in vivo), which can propagate along astrocyte 
processes and even between glial cells4,5,7,9,10, raised the possibility that glial Ca2+ waves might 
constitute an extra-neuronal signalling system in the CNS7. The subsequent demonstration 
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that rises in astrocyte [Ca2+]i, in turn, induce a [Ca2+]i rise in adjacent neurons11,12 sparked a 
flurry of studies that generated the concept of “gliotransmission” from astrocytes to neurons.  
Increases of astrocyte [Ca2+]i evoked by receptor agonists such as glutamate and 
GABA, or by uncaging of Ca2+ or IP3 (inositol trisphosphate), were reported to release 
gliotransmitters from astrocytes, including glutamate11,13-18, ATP19-21, D-serine22-24, and 
GABA25-28. (It is unknown whether [Ca2+]i also regulates the release of slower acting astrocyte-
derived factors that regulate receptor expression at synapses, such as TNF-
necrosis factor ), TGF-1 (transforming growth factor-1) and glypicans29-31).  The release 
of these gliotransmitters has been reported to generate a wide range of effects on neurons 
(summarised in Fig. 1 and described at length in ref. 32),. Glutamate release evokes an inward 
membrane current in neurons, mediated by NMDA receptors, that regulates excitability and 
synchronises action potential firing15-17,33,34. Release of glutamate and GABA, and of ATP 
which is converted to adenosine by extracellular ectoATPases, regulates synaptic vesicle 
release probability by activating presynaptic receptors18,35-38. The resulting effects on synaptic 
strength regulate whether synaptic plasticity can occur39-41, as does the release of D-serine 
which controls the amount of NMDA receptor activation occurring when glutamate is released 
at synapses22,24. These changes of neuronal function will modify information processing in 
circuit-specific ways, but a major high-level function of gliotransmitter release was suggested 
to be modulation of sleep induction, produced by the accumulation of adenosine derived from 
astrocyte-released ATP42.  
In addition to altering neuronal information processing, calcium-evoked release of 
messengers from astrocytes was suggested to regulate the energy supply to the brain in three 
important ways. First, increases of astrocyte [Ca2+]i lead to the release of arachidonic acid-
derived messengers (such as prostaglandins, epoxyeicosatrienoic acids and 20-
hydroxyeicosatetraenoic acid (20-HETE)) that modify the contraction of vascular smooth 
muscle43-45. This provides a mechanism by which the polarized morphology of astrocytes - 
with many processes around synapses, and endfeet apposed to blood vessels - could regulate 
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cerebral blood flow and energy supply46 according to the activity of synapses, the main 
consumers of energy in the brain47. Second, glutamate-evoked rises of astrocyte [Ca2+]i trigger 
the insertion of more glucose transporters into the cell membrane, facilitating glucose uptake 
from the blood when synapses are active48. Third, regulation of oxygen supply to the whole 
body may involve CO2 acidifying brainstem astrocytes, which leads to a [Ca2+]i rise and ATP 
release, which in turn increases breathing rate49.  
All this work led to the idea that astrocytes constitute a network of cells that process 
information and regulate brain energy supply in parallel with neurons. It culminated in the 
proposal that an increase in astrocyte size and complexity was crucial for the increase in 
central neural processing power that has occurred during hominid evolution50. This idea was 
reinforced by an increase in synaptic plasticity and learning seen in mice seeded with human 
astrocytes51, which propagate calcium waves four-fold faster than do rodent astrocytes50. 
Astrocytes therefore seemed to have come of age as players in information processing, and 
it was anticipated that disruptions of astrocyte calcium signalling might be important in 
diseases including epilepsy52, inflammation53, Alzheimer’s54, Huntington’s55 and HIV 
infection56.   
The second wave - the controversies 
 Throughout these exciting developments, an increasing number of conceptual 
problems were arising with the mechanisms by which [Ca2+]i is raised in astrocytes, the time 
course of that elevation, and the mechanisms by which gliotransmitters are released (Fig. 2).  
These problems and, as we shall see later, their resolution, arose in part from the methods 
used to study all of these phenomena. Demonstrating a role for gliotransmission in brain 
function requires the use of methods that manipulate astrocytes specifically. This has involved 
the use of drugs thought to alter [Ca2+]i specifically in astrocytes (which is hindered by the fact 
that many receptors, while being expressed preferentially in astrocytes, are also expressed in 
neurons), the introduction into astrocytes of agents that manipulate signalling pathways (such 
as caged calcium or IP3, and tetanus or botulinum toxin), genetic manipulations that are 
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astrocyte-specific, or the use of agents that disrupt astrocyte metabolism. It turns out that none 
of these provide a magic bullet to test the functional role of astrocyte [Ca2+]i transients32. 
 Gq-coupled metabotropic glutamate receptors (mGluRs, particularly mGluR5), which 
generate IP3 that releases calcium from internal stores, were suggested to initiate astrocyte 
calcium signalling6,13,15,43 in the developing brain, because antagonists for these receptors 
blocked astrocyte [Ca2+]i transients but not neuronal [Ca2+]i transients43 or synaptic activity6,57 
evoked by afferent stimulation. However, neurons also express mGluR5 and astrocyte 
expression of mGluR5 decreases as astrocytes mature58. Furthermore, despite originally 
reporting that in adult mice astrocyte [Ca2+]i transients are evoked by  synaptically released 
glutamate activating mGluR5 and mGluR18,57, Nedergaard’s group later reported that mRNA 
expression for these receptors in astrocytes was undetectable after three weeks postnatally59 
(see also ref. 60). Consequently, mGluR5 agonists did not raise [Ca2+]i in adult astrocytes, and 
it was concluded59 that synaptically released glutamate is insufficient to raise astrocyte [Ca2+]i. 
Caveats for this work59 include the fact that older, more ramified, astrocytes may be less easily 
isolated with all their mRNA (some of which may be in their processes), that mRNA level may 
not predict protein level, that Ca2+ signals appear to have been studied in the cells’ somata 
rather than their processes, and hence that some mGluR5 may be present in the processes 
of adult astrocytes61. 
 The intracellular signalling pathway often supposed to translate increases of 
extracellular neurotransmitter concentration into astrocyte [Ca2+]i transients, i.e. the release of 
calcium from intracellular stores downstream of mGluR5 (or other Gq-coupled receptors), has 
similarly been criticised.  Astrocyte processes very close to synapses have been reported to 
lack intracellular calcium stores62 (although this may depend on fixation conditions63), and so 
may be unable to respond to synaptic transmitter release with a [Ca2+]i transient produced by 
store release. Furthermore, when the type 2 receptor for IP3 (which is expressed far more in 
glia than in neurons64) was knocked out, although this greatly reduced the number of [Ca2+]i 
transients occurring in astrocyte somata65,66, it had no effect on neuronal excitability66, synaptic 
currents66, synaptic plasticity67 (although ACh-evoked LTP [long term potentiation] was 
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abolished68,69), neurovascular coupling70,71 or various behavioural assays72. Although it is hard 
to rule out developmental compensation in response to this lifelong deletion, these data 
challenged the notion that astrocyte [Ca2+]i transients driven by IP3-evoked Ca2+ release from 
internal stores release gliotransmitters which have a major influence on neuronal function.  
Raising astrocyte [Ca2+]i, by expressing in astrocytes a non-mammalian Gq-coupled 
receptor that could be activated by an exogenous molecule (a Designer Receptor Exclusively 
Activated by a Designer Drug, DREADD)65,70, had no effect on neuronal [Ca2+]i or excitability 
and did not modulate excitatory synaptic currents or evoke vascular effects. This is hard to 
reconcile with experiments showing that dialysis of astrocytes (from a patch pipette) with the 
calcium buffer BAPTA suppresses effects attributed to gliotransmitters18,35,37. To further 
complicate matters, raising [Ca2+]i with a Gq-coupled receptor can fail to evoke gliotransmitter 
release even when uncaging of calcium within astrocytes does73, and different Gq-coupled 
receptors can have a very different efficacy for evoking gliotransmitter release74, suggesting 
that the subcellular localization of receptors with respect to internal calcium stores may be a 
crucial determinant of gliotransmitter release.  
 The mechanism by which [Ca2+]i is raised in astrocytes will have an important influence 
on the speed of the [Ca2+]i rise, which has become a disputed issue when considering how 
astrocyte [Ca2+]i changes regulate the vasculature. Although rises of astrocyte [Ca2+]i dilate 
arterioles43,45,57, it appears that astrocyte [Ca2+]i rises may be too slow71,75,76, or occur in too 
few astrocytes77 , to produce the rapid increase of blood flow evoked by neuronal activity that 
generates BOLD fMRI signals. 
 Downstream of [Ca2+]i transients, prolonged controversy has existed over whether the 
release of gliotransmitters is mediated exocytotically1,37 (as reported in freshly dissociated and 
cultured astrocytes78,79) or by ion channels27,73,80 (as has been reviewed in detail32). We will 
return to channel-mediated release below. Exocytosis, in the case of glutamate and GABA, 
requires the presence of vesicular glutamate and GABA transporters in astrocytes. Although 
these were detected for glutamate using immunocytochemistry and single cell PCR1, this has 
been disputed on the basis of a lack of overlap of vesicular glutamate transporter (VGLUT) 
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labelling with astrocyte markers (for the plasma membrane glutamate transporter GLT-1, the 
Ca2+-binding protein S100 and the water channel aquaporin 4)81 and transcriptome data do 
not detect VGLUT1, VGLUT2, VGLUT3 or VGAT (the vesicular GABA transporter) in 
astrocytes64. RNA-seq data can exhibit false negatives, but these transporters are detected in 
neurons, suggesting that VGLUT expression is genuinely low in astrocytes, although it is hard 
to rule out a highly spatially localised expression in astrocyte compartments that do not 
express GLT-1, S100 or aquaporin 4.  
Exocytosis also requires the formation of a SNARE (Soluble NSF Attachment 
Protein REceptor) complex which mediates Ca2+-dependent release of transmitter-filled 
vesicles. Although transcriptome data64 suggest that some SNARE complex proteins are 
relatively selectively expressed in astrocytes (SNAP-23, VAMP3) or in neurons (SNAP-25, 
SNAP-47, VAMP2, syntaxin), there is no exclusively astrocytic component that could be 
knocked out to prevent transmitter exocytosis from astrocytes. Similarly, the potential calcium 
sensor for vesicle release which has the highest expression64 in astrocytes, synaptotagmin XI, 
is also expressed at a high level in neurons. An innovative approach to suppressing astrocyte 
vesicle release was provided by expressing part of the SNARE molecule VAMP2 in astrocytes, 
driven (in a doxycyclin-suppressible manner) by the GFAP (glial fibrillary acidic protein) 
promoter, to inhibit exocytotic release of transmitters from astrocytes39. This was found to alter 
synaptic transmission and plasticity39, and to reduce the pressure to sleep42, by suppressing 
the release from astrocytes of ATP, which is converted to adenosine by ecto-ATPases. The 
interpretation of this experiment depends crucially on expression of the transgene being 
specific to astrocytes, since VAMP2 is also involved in neuronal exocytosis. A paper re-
examining this issue82 suggested that the transgene was also expressed at a lower level (in a 
doxycyclin-suppressible manner) in some neurons (defined by PSA-NCAM expression), 
disagreeing with control experiments in the original reports39,42, and raising the question of 
whether the effects seen were dominated by alterations of exocytosis in astrocytes or in 
neurons83. The vigorous response published with ref. 82 
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(http://www.jneurosci.org/content/34/50/16594/reply#jneuro_el;112097) shows that this 
debate is not over yet, and the new data need to be confirmed by an independent laboratory 
(ideally using further neuronal markers), nevertheless the data in ref. 82 emphasise the 
importance of checking that supposedly astrocyte-specific transgenic lines are truly astrocyte-
specific84. An alternative approach, injection of SNARE-cleaving toxins into astrocytes has 
been shown to decrease gliotransmitter release37,85, but it is hard to rule out the possibility that 
these agents also affect trafficking to the surface membrane of ion channels that mediate 
release (see below).  
These controversies, over the receptors raising astrocyte [Ca2+]i in response to 
neuronal activity, the involvement of internal calcium stores in producing [Ca2+]i transients and 
the mechanism (if any!) by which astrocytes release transmitters in response to [Ca2+]i rises, 
left the field in a prolonged state of uncertainty, with some dismissing all the evidence as 
unsatisfactory83.  
The third wave - partial resolution of the controversies 
 The first hint of a possible explanation for some of these controversies came with the 
realisation that, just like neurons, astrocytes must be considered as comprising many different 
subcellular compartments, and that (easily detected) calcium transients occurring in the soma 
may not be telling the experimenter very much about what is happening in the fine astrocyte 
processes near synapses. Indeed, different astrocyte processes generate [Ca2+]i transients at 
different times86, and spatially localised [Ca2+]i transients in the cells’ processes occur much 
more frequently than in the somata87-89. The advent of two-photon fluorescence imaging, with 
its improved vertical spatial resolution and decreased excitation light scatter and photon 
damage, combined with the presence of Ca2+-sensing molecules in single astrocytes 
(achieved either by expressing genetically-encoded calcium indicator (GECI) proteins, or by 
dialysing cells from a patch pipette with Ca2+-sensing dyes), resulted in the characterisation of 
different types of calcium transient in different parts of the astrocyte86,90-93.  
By targeting a GECI to the membranes of astrocytes, where changes in [Ca2+]i would 
be most relevant to controlling the release of gliotransmitters, it was shown90 that [Ca2+]i 
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transients can differ in the bulk cytoplasm from those occurring just under the cell membrane. 
Indeed some [Ca2+]i transients occur mainly near the membrane, and were attributed to the 
spontaneous opening of TRPA1 (Transient Receptor Potential Ankyrin type 1) channels in the 
astrocyte membrane91, consistent with the finding that some [Ca2+]i transients in astrocyte 
processes are independent of neuronal activity86. The TRPA1 contribution to the resting [Ca2+]i 
was found to promote the insertion of GABA transporters into the astrocyte membrane, and 
thus to regulate GABAergic inhibition91. Characterization of [Ca2+]i transients at different 
locations along astrocyte processes using AM ester-88 or pipette-loaded dyes92,93 (which 
combine greater sensitivity with greater response speed than currently-available GECIs94) 
revealed [Ca2+]i elevations occurring on different spatial and temporal scales: in hippocampal 
dentate gyrus astrocytes, spontaneous synaptic transmitter release produces brief duration 
(~0.7 s) spatially-localised (~4 m) transients in astrocyte processes, while action potential 
driven release triggers larger, longer-lasting (~3 s) spatially broader (~12 m) events92. [Ca2+]i 
transients in astrocyte processes can sometimes propagate along the process86,89, into the 
soma89 and even between cells88. Both in dentate gyrus92 and in hippocampal area CA193, 
introducing the Ca2+ chelator BAPTA into an astrocyte led to an increase in the rate of synaptic 
failures (but see ref. 95 where a stronger stimulation strength was used; although the BAPTA 
concentration was high - 75 mM - in one of these studies92, 10 mM BAPTA had the same 
effect79,93). Since these studies did not add any Ca2+ to the internal solution, the resting [Ca2+]i 
is ill defined (contrast with ref. 24), and it is not possible to say whether the change of synaptic 
activity reflects BAPTA lowering the resting [Ca2+]i or buffering synaptically-evoked [Ca2+]i rises 
in the astrocyte. Despite this problem, and the fact that these studies attributed the [Ca2+]i rises 
in astrocytes and the subsequent effects on neurons to different neuro- and glio-transmitters 
(ATP and glutamate92, or glutamate and ATP or adenosine93, respectively), this work was a 
crucial step forward in the recognition that compartmentation of astrocyte [Ca2+]i rises may 
explain some of the discrepancies in the literature.  
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The best example of the importance of astrocyte Ca2+ compartmentation concerns the 
effect of knocking out IP3R2 receptors. Whereas the earlier reports65-67,70-72 discussed above 
seemed to imply that most astrocyte [Ca2+]i transients were abolished when IP3R2 was 
knocked out, it turns out that loss of this store release receptor has much less effect in the fine 
processes of astrocytes than in the soma89,96. While IP3R2 knock-out abolished all but ~10% 
of somatic [Ca2+]i transients, it spared ~40% of the [Ca2+]i transients occurring in the cells’ 
processes and, for the sites of [Ca2+]i rise that remained, there was little change in the 
frequency of transients96. Furthermore, while removal of extracellular Ca2+ had little effect on 
[Ca2+]i transients at the soma, in nearly half of the locations in processes where transients 
were generated it reduced the frequency of the transients by 50-75%. This suggests that a 
release of Ca2+ from internal stores is the main source of [Ca2+]i transients at the soma, while 
in the astrocyte processes transmembrane entry of Ca2+, presumably through endogenously 
active channels like TRPA191 or receptor-gated Ca2+-permeable ion channels, generates 30-
40% of [Ca2+]i elevations96. Interestingly, when IP3R2 receptors were knocked out, [Ca2+]i rises 
evoked in astrocytes by endothelin were greatly reduced in the somata of the cells but much 
less affected in the processes, suggesting that Ca2+ signalling evoked by this agonist may be 
mediated by release from internal stores in the soma but by direct coupling to a plasma 
membrane ion channel in the processes. Thus, there are major differences between Ca2+ 
signalling in the somata and processes of astrocytes, and overall there are at least eight-fold 
more Ca2+ transients in processes than in somata96,89. Consequently, previous conclusions65-
67,70-72, based on knocking out IP3R2 receptors and assuming (on the basis of a lack of somatic 
Ca2+ responses) that astrocyte Ca2+ signalling then has little functional effect on neurons, 
require re-examination.  
 The importance for understanding function, of characterising [Ca2+]i rises in the 
processes of astrocytes, is illustrated by papers examining whether astrocyte [Ca2+]i rises are 
fast enough to drive the local increases of blood flow evoked by neuronal activity. While [Ca2+]i 
rises in astrocyte somata may be too slow71,75,76 to generate rapid blood flow increases, 
examination of [Ca2+]i transients in astrocyte processes suggests that they are faster than in 
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somata97, and occur before or with a similar time course to the increase of blood flow88,98,99.The 
lack of effect of IP3R2 receptor knockout on blood flow responses70,71, together with data 
showing that 30-40% of astrocyte process [Ca2+]i rises are initiated by transmembrane Ca2+ 
entry96, suggests that active neurons release agents that gate Ca2+-permeable ion channels 
in astrocyte processes (for example AMPA98,100, NMDA100,101 or P2X100-102 receptors, or 
TRPA191 channels). This raises the question of how [Ca2+]i rises evoked in astrocyte 
processes around synapses lead to the release of vasoactive messengers at the spatially-
distant endfeet made by astrocytes onto vessels. The lack of effect on blood flow responses 
of knocking out IP3R2 receptors rules out the possibility that a [Ca2+]i wave produced by 
regenerative IP3 generation and Ca2+ release from endoplasmic reticulum stores propagates 
through the cell. Instead, either vasoactive messengers (NO, arachidonic acid derivatives) 
generated in astrocyte processes near synapses may diffuse to the nearest vessel, or a [Ca2+]i 
wave generated by Ca2+-induced Ca2+ release from stores mediated by ryanodine receptors103 
or by Ca2+-induced ATP release and activation of ATP receptors104 may transmit the signal 
from the astrocyte’s synapse-wrapping processes to its endfeet. 
 Other novel pathways that can raise [Ca2+]i in astrocytes have also been suggested. 
For glutamate, the canonical Gi signalling pathway activated by mGluR2 and mGluR3 
receptors inhibits cAMP production, however activation of these receptors (the expression of 
which, unlike mGluR5, has not been questioned in the adult59) has been suggested to raise 
[Ca2+]i in the processes of astrocytes105. This may involve activation of Ca2+ release from 
stores or entry to the cell mediated by the G protein’s subunits. In addition, glutamate75 and 
GABA106 transporters have been suggested to raise astrocyte [Ca2+]i in response to neuronal 
activity. This may be mediated by reversed operation of Na+/Ca2+ exchangers106, following an 
uptake-evoked rise of [Na+]i. Astrocyte [Ca2+]i is also regulated by the modulatory 
neurotransmitters noradrenaline107 (via 1 receptors) and acetylcholine108 (via muscarinic 
receptors), which are released from wide ranging axons with somata in the locus coeruleus (a 
region involved in arousal, attention and memory) and the nucleus basalis of Meynert (an area 
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involved in arousal, learning and reward), respectively. These responses are developmentally 
regulated in the opposite direction to those generated by mGluR5, being barely detectable 
before the end of the first post-natal week108. Recent in vivo work has revealed that locomotion 
or an aroused state evoke a large noradrenaline-mediated astrocyte [Ca2+]i elevation over a 
broad spatial area109,110, while stimulation of the nucleus basalis of Meynert evokes similar 
acetylcholine-mediated [Ca2+]i elevations69,111. Importantly, the noradrenaline results were 
obtained in unanaesthetized animals, and so were not compromised by the suppressive effect 
of anaesthetics on astrocyte Ca2+ transients112. The significance of these results is discussed 
below. 
As indicated above, in our view the jury is still out on whether gliotransmitters are 
exocytosed from astrocytes, but new developments make that issue less crucial. First, recent 
work has provided molecular candidates for ion channels that have been suggested80 to 
release neurotransmitters from astrocytes: both GABA and glutamate can be released from 
astrocytes via Ca2+-activated bestrophin-1 anion channels (despite the apparently low 
expression of mRNA for this channel in astrocytes58,64) and, surprisingly, normally K+-selective 
TREK (Tandem of P-domains in a Weakly Inward rectifying K+ channel - related K+ channel) 
two-pore domain channels27,113,114. Furthermore, raising the proton concentration within 
cerebellar astrocytes (Bergmann glia) using channelrhodopsin evokes glutamate release via 
an as yet unidentified H+-gated mechanism (cf. ref. 49 on brainstem astrocytes) and this 
mechanism contributes to glutamate release during ischaemia115. Second, there is increasing 
awareness that changes of astrocyte [Ca2+]i can have effects on neurons not by releasing 
substances but via changes in the activity of transporters in the astrocyte membrane. 
Astrocyte [Ca2+]i rises via TRPA1 channels increase the insertion of GABA transporters into 
the astrocyte membrane and thus regulate GABAergic effects on neurons without a need for 
the astrocyte to release GABA91. Similarly, Gq-coupled mGluRs increase glutamate uptake 
currents116 and membrane-insertion of GLAST glutamate transporters117, and thus decrease 
glutamate effects on nearby neurons117 (but see ref. 118), and conceivably the surface mobility 
of glutamate transporters119 could be altered by [Ca2+]i changes. Alterations of astrocyte 
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morphology driven by [Ca2+]i changes120,121 will also contribute to altering the efficiency of 
astrocyte transporters in regulating neurotransmitter effects on neurons. Finally, the increase 
of Na+/Ca2+ exchange activity that is generated by increases of astrocyte [Ca2+]i following 
transmitter-induced calcium release from internal stores has been reported to raise [Na+]i 
sufficiently to increase sodium pump activity, leading to a decrease of [K+]o (or less increase 
during neuronal activity) and local hyperpolarization of neurons122. This reduced spontaneous 
excitatory (but not inhibitory) synaptic activity, but decreased failures of action potential evoked 
excitatory synaptic transmission122. The discovery of these mechanisms for modulating 
neuronal synaptic currents by altering astrocyte transmitter uptake or sodium pump activity 
implies that future studies wishing to attribute the effects of changes of astrocyte [Ca2+]i to 
altered gliotransmitter release will first need to rule out  (as in ref. 79) changes in the activity 
of a range of astrocyte membrane transporters. 
Outlook for the future 
  With the discovery of a plethora of astrocyte [Ca2+]i transients with different spatial 
locations and temporal dynamics, new ways in which [Ca2+]i can be raised, and novel 
mechanisms by which astrocytes can modulate neuronal function downstream of the [Ca2+]i 
rises, the field is on a more secure footing than it was 10 years ago (Fig. 3). In this section we 
will highlight what we see as the most important questions to be resolved in the future. 
Methodological advances needed for this progress have been dealt with in three recent 
reviews123-125. 
How do locally and globally-evoked [Ca2+]i changes interact? In brain slices, astrocyte 
[Ca2+]i transients generated locally either spontaneously86,91 or by local release of 
transmitters41,92,93 such as glutamate, GABA and ATP, are readily detected. In vivo, however, 
these can be greatly outweighed by noradrenaline- and ACh-mediated [Ca2+]i transients 
evoked by movement or attention changes (or nucleus basalis stimulation)69,109,110, which 
potentiate the [Ca2+]i rise produced by the locally released transmitters. These [Ca2+]i 
transients evoke a long-term potentiation of local neuronal responses (which depends on 
store-mediated release of Ca2+ in astrocytes, and subsequent D-serine and ATP 
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release)69,103,111. The locus coeruleus and nucleus basalis of Meynert comprise a relatively 
small number of cells (~35,000 for the locus coeruleus in humans), with widely ranging axons, 
which cannot mediate very specific modulation of the neural circuitry, and so their activation 
evokes an astrocyte [Ca2+]i rise more or less globally, in many brain areas109. It therefore 
seems likely that these pathways serve to prime astrocytes to globally modulate neuronal 
function in certain behavioural states. The underlying mechanisms, and how they are 
modulated in disorders of noradrenergic or cholinergic function, are important questions for 
the future. 
How are astrocyte [Ca2+]i transients decoded? In other cell types it has been shown that 
the frequency and time course of [Ca2+]i transients determines their downstream effect126. At 
present we have no information on how the variety of [Ca2+]i transients seen in astrocytes, with 
different spatial and temporal characteristics86,88-93, are decoded into functional effects that are 
short term (e.g. modulation of synaptic transmission) and long term (e.g. modulation of 
synaptic existence by release of factors like glypicans or regulation of synaptic pruning). Is it 
the mean [Ca2+]i that matters, the amplitude of [Ca2+]i transients, their duration, or all of these? 
As noted above, it is common for studies probing the role of astrocyte [Ca2+]i transients to 
introduce BAPTA into astrocytes with a solution lacking added Ca2+, producing a reduction of 
baseline [Ca2+]i in addition to an increase of buffering power. Future work will need to 
determine which of these has the dominant effect on the release of gliotransmitters or the 
activity of proteins in the astrocyte membrane. A related issue is that, conceivably, some 
BAPTA could leak out of astrocytes via gap junctional hemichannels and have an effect by 
lowering the local [Ca2+]o and suppressing synaptic transmission (although dyes of a similar 
molecular weight do not appear to leak out of the cells): this could be tested by conducting 
such experiments in the presence of hemichannel blockers. 
Which other major factors regulate astrocyte [Ca2+]i? We have restricted our review to the 
most well known neurotransmitters that may regulate astrocyte [Ca2+]i. However, new 
modulators of astrocyte  [Ca2+]i are likely to be discovered, and a case has already been made 
for protons49, cannabinoids127,128, polyphosphate129 and endothelin130 in this regard. Although 
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it has been widely assumed that the majority of neuronally-evoked astrocyte [Ca2+]i transients 
reflect release of neurotransmitters at presynaptic terminals, neuronal depolarization may 
instead raise astrocyte [Ca2+]i by action potential evoked release of substances from 
postsynaptic dendrites, including glutamate, ATP and cannabinoids128,131. Astrocyte Ca2+ 
signalling and its effects are also, as for neuronal signalling, likely to show plasticity 
themselves95. 
Which is more important: release of gliotransmitters or alteration of astrocyte 
membrane proteins? A gliotransmitter-sceptic might assert that many of the phenomena 
attributed to gliotransmitter release can in fact be explained by astrocyte-intrinsic effects, 
specifically changes in the activity or expression of membrane transporters. Thus, increases 
in the failure rate of action potential evoked synaptic transmission seen when astrocyte [Ca2+]i 
is buffered might theoretically reflect a reduction of the astrocyte Ca2+-evoked decrease of 
[K+]o produced by increased sodium pump activity122, while changes in the amplitude of 
synaptic currents might reflect Ca2+-driven changes of neurotransmitter transporter level in the 
surface membrane of astrocytes91,116,117. Although occlusion experiments, showing that 
signalling to transmitter receptors on neurons is downstream of astrocyte [Ca2+]i changes, can 
argue against the former idea, we believe that future research will increasingly need to 
consider astrocyte-intrinsic explanations of changes in neuronal function induced by astrocyte 
[Ca2+]i transients. Astrocytes may also release factors other than small molecule transmitters, 
including the calcium-binding protein S100132. 
Does cyclic nucleotide signalling have similar effects to Ca2+? Most research is done on 
astrocyte Ca2+ signalling because of the easy availability of indicators to monitor [Ca2+]i. Yet 
many astrocyte neurotransmitter receptors evoke changes of cAMP (cyclic AMP) 
concentration rather than [Ca2+]i. There is almost certainly a whole world of cAMP-mediated 
effects in astrocytes, influencing membrane proteins, astrocyte morphology and thus neuronal 
function, which is waiting to be discovered. 
Does all this happen in other glia? While more than a decade of research has now been 
carried out on astrocyte Ca2+ signalling, this area of research has barely begun for 
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oligodendrocytes and microglia. The lessons learnt from the pioneering studies of astrocyte 
[Ca2+]i transients will surely be helpful to those studying whether Ca2+ signalling is involved in 
regulating myelination or immune cell function. 
Conclusion 
 From our perspective, the astrocyte Ca2+ signalling field seems in robust good health. 
Controversies remain, but if one examines fields of neuronal physiology that are at a similar 
developmental stage (e.g. the role of neuronal oscillations in brain function, determining what 
fMRI really measures, assessing how the cortical canonical circuit works, defining what the 
cerebellum does) they seem to show similar growing pains to the astrocyte Ca2+ field. 
Constructively handled disagreements are a useful stimulus to further research. We look 
forward to the fourth wave! 
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Figure Legends 
Figure 1. The first wave. Elevations of astrocyte [Ca2+]i evoked by G protein coupled 
receptors activated by glutamate, GABA and ATP (or ADP) have been reported to evoke the 
release of the gliotransmitters ATP, glutamate, D-serine and GABA. These can modulate 
neuronal activity postsynaptically, notably by glutamate and D-serine inducing NMDA receptor 
mediated currents. They can also modulate transmitter release probability by acting on 
presynaptic receptors. Astrocyte P2X and NMDA receptors represent other channel mediated 
sources of [Ca2+]i elevation in astrocytes. Ca2+ waves can spread through the astrocyte’s 
processes to the soma, and to its vascular endfeet where vasoactive messengers are released 
(PG, prostaglandin; 20-HETE, 20-hydroxyeicosatetraenoic acid; EETs, epoxyeicosatrienoic 
acids). Astrocyte morphology has been distorted to define the location of signalling processes. 
Figure 2. The second wave controversies. 1. mGluR5 is absent in adult astrocytes, but they 
still show glutamate-evoked [Ca2+]i transients. 2. Knock-out of the gene for IP3R2 receptors on 
astrocyte calcium stores suppresses calcium transients at the soma, but does not affect many 
functions attributed to [Ca2+]i-driven transmitter release from astrocytes. 3. Raising astrocyte 
[Ca2+]i using a DREADD did not evoke functions attributed to [Ca2+]i-driven transmitter release 
from astrocytes. 4. [Ca2+]i transients seem too slow to account for rapid blood flow increases. 
5. There is debate about whether astrocytes express the VGLUTs and VGAT needed to 
package glutamate and GABA into vesicles for exocytosis. 6. Inhibiting SNARE-driven 
exocytotic release from astrocytes with a dominant negative construct (dnSNARE) suppresses 
effects attributed to gliotransmitter (GlioT) release (6a), but the dnSNARE may also be 
expressed in neurons and suppress their release of neurotransmitter (NeuroT) (6b).  
Figure 3. The third wave and the future. 1. [Ca2+]i transients in the processes of astrocytes 
(1a) differ from those in the soma (1b) in terms of frequency, kinetics and spatial spread. 2. 
[Ca2+]i transients in the processes of astrocytes (2a) depend roughly equally on Ca2+ entry 
from the extracellular space via ion channels (40%) and on Ca2+ release from intracellular 
stores (60%), while those in the soma (2b) depend largely (90%) on Ca2+ release from the 
intracellular stores. 3. [Ca2+]i transients can be generated by Ca2+ entry through spontaneously 
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opening TRPA1 channels or neurotransmitter-gated channels (3a), by mGluR2 or mGluR3 
(3b), and by neurotransmitter uptake raising [Na+]i and reversing Na+/Ca2+ exchange (3c). 4. 
[Ca2+]i rises may release transmitters via ion channels like Best-1 as well as via exocytosis. 5. 
[Ca2+]i rises alter the surface expression of neurotransmitter transporters. 6. Activation of 
Na+/Ca2+ exchange by a [Ca2+]i rise can raise [Na+]i and activate the sodium pump, lowering 
[K+]o and hyperpolarizing nearby neurons. This increases the release probability (Prelease) 
for action potential driven vesicle release, and thus decreases synaptic failure rate. 7. ATP 
released by a [Ca2+]i rise may act on P2X or P2Y receptors to raise [Ca2+]i further along the 
cell, propagating a Ca2+ wave along the cell (7a), or be converted to adenosine which acts on 
presynaptic receptors to increase (A2A) or decrease (A1) transmitter release (7b). 8. 
Noradrenaline released from locus coeruleus neurons, and ACh released from nucleus basalis 
neurons produce large [Ca2+]i rises in astrocytes. 
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